Inside Basecamp Research, the AI startup turning evolution into training data
AI startup Basecamp Research raised $140M from Nvidia and Anthropic to train biological AI models on massive novel genetic datasets for drug discovery.
Basecamp Research, a London-based AI startup, has secured $140 million in funding from investors including Nvidia and Anthropic's Anthology Fund. The company is developing biological AI models, named EDEN, trained on genetic material from diverse, understudied organisms to design new drugs and therapies, such as in-body cell treatments for cancer. The training dataset, comprising around 15 trillion DNA 'tokens', is designed to overcome the limitations of public genome databases and aims to grow to over one quadrillion tokens.
- Basecamp Research raised $140M from Nvidia, Anthropic, and others to develop biological AI.
- The EDEN model is trained on DNA data from underrepresented species to design new therapies.
- The company aims to create in-body cell therapies and uses a massive, novel biological dataset.
- The training dataset is comparable in size to large language model corpora, focusing on genetic sequences.
From the original article
14 min read at the-decoder.com
Basecamp Research has raised $140 million from investors including Nvidia and Anthropic's Anthology Fund. The London company trains AI models on genetic material from rainforests, oceans, and hot springs to design antibiotics and tools for cell therapies.
By Maximilian Schreiner · the-decoder.com
A short excerpt; the article and its images belong to the publisher. Summary, key facts and assessment above are AI-written from the article and can be wrong.